Crescent Biopharma, Inc. Common Stock

CBIO us
$13.99
▼ 0.25 (-1.76%)
Volume: 228,685 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 27
  • 21d momentum -22.4%
  • RSI 31
🎯 Pullback 65
  • RSI 31 near lows
  • Near lower Bollinger band
  • -21.4% vs 20MA
💎 Value 58
  • -49% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)31.5
MACD-0.629
MA trendMixed
ATR10.12%
21d mom.-22.4%
63d mom.-24.6%
vs 20MA-21.4%
RVOL(20)0.43×
52w low · 9 52w high · 27
-49.0% from 52-week high
20d support 13 · resistance 22

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$529M
PER—
PBR3.24
PSR44.51
EPS$-3.93
ROE-89.4%
ROA-79.9%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-2.12
week1M3M6M1YYTD
-17.17% -22.36% -24.62% +3.63% +7.78% +26.26%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
0/10
🐻 Bear
10/10

14d momentum -33.00%, daily vol 4.87%. Crescent Biopharma, Inc. Common Stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.